|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Challenges and Solution To Pharmaceutical Industry With Reference to Patent Laws |
| Authors Name: | D ISRAEL SELVARAJ |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_214439
|
| Published Paper Id: | IJNRD2402312 |
| Published In: | Volume 9 Issue 2, February-2024 |
| DOI: | |
| Abstract: | While India signed the TRIPS Agreement, it led to lot of changes in the country’s patent regime. The two important provisions of Patents Act, 1970, were amended which was helping the generic companies for huge amount of benefit. While Product patents were introduced for pharmaceutical innovations, patent protection was provided for 20 years. The Government of India while incorporating the TRIPS Agreement by amending two provisions in the Patents Act, which reduce the impact on the generic companies. The first change was done in Section 3(d) which does not allow patents by way of minor modifications in the existing product. The primary objective of this provision was to eradicate the chances or probability of ever greening of patents. Hence we understand that Section 3(d) ensures that public domain allows the generic companies to continue operating in the industry |
| Keywords: | TRIPS, INTELLECTUAL PROPERTY, PHARMACEUTICAL INDUSTRY, PATENT LAW |
| Cite Article: | "Challenges and Solution To Pharmaceutical Industry With Reference to Patent Laws", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 2, page no.d120-d123, February-2024, Available :http://www.ijnrd.org/papers/IJNRD2402312.pdf |
| Downloads: | 000118761 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2402312 Registration ID: 214439 Published In: Volume 9 Issue 2, February-2024 DOI (Digital Object Identifier): Page No: d120-d123 Country: CHENNAI, TAMILNADU, India Research Area: Other Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2402312 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2402312 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn